New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored health insurance may not foot the bill.
New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are expected to significantly boost consumer demand. However, employer-sponsored health insurance plans might not cover the costs of these breakthrough medications. This situation could lead to substantial out-of-pocket…
Market Samachar is a news aggregator. This article was originally published by CNBC. Tap the button above to read the full story on their site.